FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-enzalutamide-non-metastatic-castration-sensitive-prostate-cancer-biochemical-recurrence?utm_medium=email&utm_source=govdelivery